Whole blood sample stability as an analytical parameter should be assessed when developing pharmacodynamic flow cytometry assays. Sample stability will determine the robustness of detecting not only ...

Myelodysplastic syndromes (MDS) describe cancers resulting from abnormal cells in the bone marrow. The abnormal bone marrow cells generate defective blood cells, which die earlier than normal blood ...

Integrates state-of-the-art flow cytometry clinical trial services with leading genomics, proteomics, and molecular pathology solutions under one roof HUNTSVILLE, Ala., July 11, 2023 /PRNewswire/ -- ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced the worldwide commercial launch of a new automated instrument, BD FACSDuet Premium Sample Preparation System. It prepares ...

Flow cytometry has become a key analytical technique in clinical trials. Through its multiparametric analysis, single-cell resolution, and high-throughput evaluation capabilities, flow cytometry can ...

Leading the way with the industry’s largest portfolio of CE-IVD labeled flow cytometry reagents in the market, Beckman Coulter Life Sciences announces that it has received a EU Quality Management ...

Flow cytometry is crucial for diagnosing hematological malignancies. However, the rising number of tests and ongoing labor shortages are placing significant pressure on both the lab and its staff. Lab ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced a strategic collaboration with Navigate BioPharma Services, Inc. The tie-up is aimed at exploring opportunities to develop ...

The following companies offer flow cytometry instruments, equipment, and/or reagents for clinical and laboratory purposes. Please contact the companies directly for more information concerning ...

The MarketWatch News Department was not involved in the creation of this content. CHICAGO, June 11, 2024 /PRNewswire/ -- The global flow cytometry market, valued at $5.1 billion in 2024, is primed for ...